Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Sep 4, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | NYSE | Drug Manufacturers - General | A | $698.32B | $737.83 | 0.36% | $18.75B | 48.07x | 4.52 | United States | 65 |
| MU | MICRON TECHNOLOGY INC | NASDAQ | Semiconductors | A | $132.86B | $118.72 | 0.20% | $16.22B | 21.24x | 0.55 | United States | 52 |
| RYAAY | RYANAIR HOLDINGS PLC | NASDAQ | Airlines | A | $33.03B | $62.09 | 1.79% | $3.44B | 18.88x | 1.49 | Ireland | 37 |
| SOLV | SOLVENTUM CORP | NYSE | Health Information Services | A | $12.35B | $71.40 | -0.58% | $1.29B | 32.75x | 3.45 | United States | 34 |
| CPA | COPA HOLDINGS SA | NYSE | Airlines | A | $4.84B | $117.56 | 1.11% | $1.12B | 8.08x | 1.42 | Panama | 41 |
| BGC | BGC GROUP INC | NASDAQ | Capital Markets | A | $4.64B | $9.79 | 1.24% | $404.32M | 31.58x | 4.07 | United States | 47 |
| TPC | TUTOR PERINI CORP | NYSE | Engineering & Construction | A | $3.11B | $59.03 | -0.17% | -$36.35M | -23.33x | 3.06 | United States | 20 |
| IHS | IHS HOLDING LTD | NYSE | Telecom Services | A | $2.43B | $7.23 | 0.70% | N/A | 21.26x | -16.94 | United Kingdom | 25 |
| DBD | DIEBOLD NIXDORF INC | NYSE | Software - Application | A | $2.19B | $59.84 | 0.40% | $275.40M | -176.00x | 2.40 | United States | 17 |
| FIVN | FIVE9 INC | NASDAQ | Software - Infrastructure | A | $2.05B | $26.48 | 0.53% | $98.42M | 203.69x | 1.38 | United States | 46 |
| ARDT | ARDENT HEALTH PARTNERS INC | NYSE | Medical Care Facilities | A | $1.83B | $12.79 | 0.95% | $541.00M | 6.88x | 2.70 | United States | 48 |
| NTCT | NETSCOUT SYSTEMS INC | NASDAQ | Software - Infrastructure | A | $1.76B | $24.73 | 0.37% | -$294.85M | -4.83x | 0.40 | United States | 28 |
| AVDL | AVADEL PHARMACEUTICALS PLC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $1.42B | $14.66 | -2.14% | $7.86M | -488.67x | 1.06 | Ireland | 35 |
| GBX | GREENBRIER COMPANIES INC | NYSE | Railroads | A | $1.42B | $45.82 | -1.34% | $541.60M | 6.25x | 1.78 | United States | 34 |
| DCO | DUCOMMUN INC | NYSE | Aerospace & Defense | A | $1.34B | $89.74 | -1.33% | $98.47M | 37.86x | 0.63 | United States | 43 |
| LMB | LIMBACH HOLDINGS INC | NASDAQ | Engineering & Construction | A | $1.26B | $108.56 | -2.22% | $63.54M | 35.02x | 1.01 | United States | 54 |
| EVER | EVERQUOTE INC | NASDAQ | Internet Content & Information | A | $841.26M | $23.04 | -0.95% | $54.06M | 17.72x | 0.42 | United States | 54 |
| AKBA | AKEBIA THERAPEUTICS INC | NASDAQ | Biotechnology | A | $819.42M | $3.12 | 0.32% | $10.87M | -14.18x | 11.62 | United States | 28 |
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | A | $771.21M | $9.67 | -2.13% | $19.78M | 42.04x | 0.43 | United States | 43 |
| NRDS | NERDWALLET INC | NASDAQ | Internet Content & Information | A | $756.30M | $10.15 | -1.07% | $51.20M | 26.03x | 0.28 | United States | 58 |
| TBPH | THERAVANCE BIOPHARMA INC | NASDAQ | Biotechnology | A | $691.71M | $13.74 | -0.76% | $48.42M | 54.94x | 0.90 | Cayman Islands | 39 |
| LYTS | LSI INDUSTRIES INC | NASDAQ | Electronic Components | A | $682.90M | $22.76 | -0.09% | $44.29M | 30.76x | 0.74 | United States | 58 |
| KMDA | KAMADA LTD | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $400.81M | $6.97 | -0.71% | $34.21M | 21.12x | 0.42 | Israel | 51 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $199.04M | $23.84 | -0.46% | $11.32M | 26.79x | 0.25 | United States | 44 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.